Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-11-30

FDA Approved: THYQUIDITY — Original Application (Oliva Therapeutics, LLC)

View source ↗

Summary

FDA approved THYQUIDITY (levothyroxine sodium) from Oliva Therapeutics, LLC via an Original New Drug Application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • THYQUIDITY (LEVOTHYROXINE SODIUM)

Snippet

ORIG AP for THYQUIDITY (LEVOTHYROXINE SODIUM)